These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38963885)

  • 21. A technological and regulatory outlook on CRISPR crop editing.
    Globus R; Qimron U
    J Cell Biochem; 2018 Feb; 119(2):1291-1298. PubMed ID: 28731201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimates and implications of the costs of compliance with biosafety regulations in developing countries.
    Falck-Zepeda J; Yorobe J; Husin BA; Manalo A; Lokollo E; Ramon G; Zambrano P; Sutrisno
    GM Crops Food; 2012; 3(1):52-9. PubMed ID: 22614639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of agribiotechnology and biosafety regulations used to assess safety of genetically modified crops in Bangladesh.
    Nasiruddin KM; Nasim A
    J AOAC Int; 2007; 90(5):1508-12. PubMed ID: 17956000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome editing of crops: A renewed opportunity for food security.
    Georges F; Ray H
    GM Crops Food; 2017 Jan; 8(1):1-12. PubMed ID: 28075688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory considerations in the development and application of biotechnology in Japan.
    Yamanouchi K
    Rev Sci Tech; 2005 Apr; 24(1):109-15. PubMed ID: 16110881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General principles for risk assessment of living modified organisms: lessons from chemical risk assessment.
    Hill RA; Sendashonga C
    Environ Biosafety Res; 2003; 2(2):81-8. PubMed ID: 15612274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Genetically Modified Organism Medicinal Framework in Europe, United States, and Japan: Underlying Scientific Principles and Considerations Toward the Development of Gene Therapy and Genetically Modified Cell-Based Products.
    Bachtarzi H; Farries T
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):114-128. PubMed ID: 31111736
    [No Abstract]   [Full Text] [Related]  

  • 28. Next-generation biocontainment systems for engineered organisms.
    Lee JW; Chan CTY; Slomovic S; Collins JJ
    Nat Chem Biol; 2018 Jun; 14(6):530-537. PubMed ID: 29769737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of agricultural biotechnology and biosafety regulations used to assess the safety of genetically modified crops in Iran.
    Mousavi A; Malboobi MA; Esmailzadeh NS
    J AOAC Int; 2007; 90(5):1513-6. PubMed ID: 17956001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. There's a long, long trail a-winding: the complexities of GM foods regulation, a cautionary tale from the UK.
    Burke DC
    GM Crops Food; 2012; 3(1):30-9. PubMed ID: 22614637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No country for new seeds: food and environmental security implications of Mexico's intended ban on GM crops.
    de la Barrera E; Aguirre-Pérez IA; Ibarra-Otero BA; Villalvazo-Figueroa EA; Díaz-Álvarez EA
    Transgenic Res; 2020 Feb; 29(1):165-170. PubMed ID: 31912406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of GM crops in Argentina.
    Burachik M
    GM Crops Food; 2012; 3(1):48-51. PubMed ID: 22614638
    [No Abstract]   [Full Text] [Related]  

  • 33. When Policy Meets Practice: The Dilemma for Guidance on Risk Assessment Under the Cartagena Protocol on Biosafety.
    Hokanson KE
    Front Bioeng Biotechnol; 2019; 7():82. PubMed ID: 31119127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The science and politics of plant biotechnology--a personal perspective.
    Vasil IK
    Nat Biotechnol; 2003 Aug; 21(8):849-51. PubMed ID: 12894193
    [No Abstract]   [Full Text] [Related]  

  • 35. Options to Reform the European Union Legislation on GMOs: Scope and Definitions.
    Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
    Trends Biotechnol; 2020 Mar; 38(3):231-234. PubMed ID: 32059122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk, regulation and biotechnology: the case of GM crops.
    Smyth SJ; Phillips PW
    GM Crops Food; 2014 Jul; 5(3):170-7. PubMed ID: 25437235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GM in the media.
    Moses V
    GM Crops Food; 2012; 3(1):3-5. PubMed ID: 22430850
    [No Abstract]   [Full Text] [Related]  

  • 38. EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead.
    Devos Y; Aguilera J; Diveki Z; Gomes A; Liu Y; Paoletti C; du Jardin P; Herman L; Perry JN; Waigmann E
    Transgenic Res; 2014 Feb; 23(1):1-25. PubMed ID: 23963741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Important points in virus research using recombinant DNA technology].
    Nikaido T; Takeuchi K
    Uirusu; 2007 Jun; 57(1):91-100. PubMed ID: 18040159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of genetically modified crop governance, issues and challenges in Malaysia.
    Andrew J; Ismail NW; Djama M
    J Sci Food Agric; 2018 Jan; 98(1):12-17. PubMed ID: 28898466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.